Use of Rybelsus® in young children under age 18 is not advised as it is not FDA-approved or studied in pediatric populations. Helen, 69, with diabetes and kidney disease, obtained coverage through Medicare Part D after her endocrinologist submitted prior therapy records. For people with diabetes, the inability to pay…